Thyrocare Technologies Limited
Thyrocare Technologies Limited has informed the Exchange regarding allotment of 10,61,07,794 securities pursuant to Bonus at its meeting held on December 01, 2025 |SUBJECT: Allotment of Securities
Thyrocare Technologies Limited has informed the Exchange regarding allotment of 10,61,07,794 securities pursuant to Bonus at its meeting held on December 01, 2025 |SUBJECT: Allotment of Securities
Thyrocare Technologies Limited has informed the Exchange regarding allotment of 10,61,07,794 securities pursuant to Bonus at its meeting held on December 01, 2025 |SUBJECT: Allotment of Securities
L&T Technology Services Limited has informed the Exchange regarding a press release dated December 01, 2025, titled “”L&T Technology Services Transforms Respiratory Diagnostics with NVIDIA AI-Powered Digital Twin Technology “. |SUBJECT: Press Release
Adani Green Energy Limited has informed the Exchange regarding ‘Operationalization of Projects’. |SUBJECT: Updates
Voting results of Postal Ballot and Report of Scrutinizers is enclosed. |SUBJECT: Shareholders meeting
South West Pinnacle Exploration Limited has informed the Exchange regarding ‘Press Release on South West Pinnacle Exploration Ltd. becoming accredited prospecting agency to explore it s own coal block in Jharkhand’. |SUBJECT: Updates
SML Mahindra Limited has informed the Exchange regarding Monthly Business Updates for the month of November 2025 |SUBJECT: Monthly Business Updates
Sterling and Wilson Renewable Energy Limited has informed the Exchange regarding a press release dated December 01, 2025, titled “SWREL announces marquee orders worth approx. INR 1,381 cr from Adani Green Energy”. |SUBJECT: Press Release
DEN NETWORKS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |SUBJECT: Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
Lupin Limited has informed the Exchange regarding a press release dated December 01, 2025, titled “Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg (Pegfilgrastim-unne)”. |SUBJECT: Press Release